PRINCIPAL FINANCIAL GROUP INC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$41,000
-38.8%
62,766
+2.1%
0.00%
Q4 2021$67,000
-58.1%
61,472
-30.2%
0.00%
Q3 2021$160,000
-26.9%
88,117
+6.2%
0.00%
Q2 2021$219,000
-29.1%
82,983
-3.3%
0.00%
Q1 2021$309,000
+45.1%
85,801
+1.1%
0.00%
Q4 2020$213,000
+30.7%
84,902
+31.5%
0.00%
Q3 2020$163,000
-29.4%
64,573
-8.1%
0.00%
Q2 2020$231,000
+87.8%
70,302
+39.9%
0.00%
Q1 2020$123,000
-44.3%
50,260
+7.3%
0.00%
Q4 2019$221,000
+16.9%
46,844
+6.2%
0.00%
Q3 2019$189,000
-19.6%
44,107
+9.3%
0.00%
Q2 2019$235,000
+63.2%
40,341
+8.1%
0.00%
Q1 2019$144,000
+105.7%
37,316
-0.4%
0.00%
Q4 2018$70,000
-51.0%
37,464
-16.0%
0.00%
Q3 2018$143,000
+22.2%
44,623
+14.4%
0.00%
Q2 2018$117,000
-28.7%
38,990
-6.8%
0.00%
Q1 2018$164,000
-5.2%
41,854
-0.2%
0.00%
Q4 2017$173,000
+38.4%
41,957
+105.8%
0.00%
Q3 2017$125,000
-16.7%
20,386
-15.2%
0.00%
Q2 2017$150,000
+5.6%
24,046
+7.5%
0.00%
Q1 2017$142,000
+18.3%
22,3730.0%0.00%
Q4 2016$120,000
-2.4%
22,373
+2.6%
0.00%
Q3 2016$123,000
+5.1%
21,806
+2.0%
0.00%
Q2 2016$117,000
-22.0%
21,388
+5.5%
0.00%
Q1 2016$150,000
-9.1%
20,264
+2.1%
0.00%
Q4 2015$165,000
-5.7%
19,851
+2.3%
0.00%
Q3 2015$175,000
-15.9%
19,404
+12.2%
0.00%
Q2 2015$208,000
+47.5%
17,292
+32.1%
0.00%
Q1 2015$141,000
+27.0%
13,089
-52.5%
0.00%
Q2 2014$111,00027,5340.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders